Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nebula Genomics

Nebula Genomics?uq=zwK81hPB
2017 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$4.3M LATEST DEAL AMOUNT
11 INVESTORS
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Social/Platform Software
Other Industries
Other Pharmaceuticals and Biotechnology
Application Software
Primary Office
  • Boston, MA
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nebula Genomics’s full profile, request a free trial.

Nebula Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 29-Aug-2018 $4.3M 00.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Nebula Genomics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Fenbushi Capital Venture Capital Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
GreatPoint Ventures Venture Capital Minority 000 0000 000000 0
Heartbeat Labs Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Nebula Genomics Executive Team (4)

Name Title Board
Seat
Contact
Info
Kamal Obbad Co-Founder & Chief Executive Officer
Louise Callagy Chief Marketing Officer
Dennis Grishin Ph.D Co-Founder & Chief Scientific Officer
George Church Ph.D Co-Founder